Pharmacodynamics of Commonly Prescribed Medications: An Overview

QUESTION

• Diovan 80 mg po OD
• Prinivil 10 mg po OD
• Omeprazole 20 mg OD
• Lantus 18 units subcutaneous q AM
• Humalog 19 units subcutaneous TID before meals

Explain the pharmacodynamics of the above medications.

ANSWER

Pharmacodynamics of Commonly Prescribed Medications: An Overview

Introduction

Pharmacodynamics refers to the study of the biochemical and physiological effects of drugs on the body and their mechanisms of action. Understanding the pharmacodynamics of medications is crucial for healthcare professionals, including nurses, as it allows them to comprehend how drugs interact with the body to produce therapeutic effects. In this essay, we will explore the pharmacodynamics of the medications mentioned below:

Diovan (valsartan) 80 mg po OD:

Diovan belongs to the angiotensin II receptor blocker (ARB) class of antihypertensive medications. It selectively blocks the angiotensin II type 1 receptors, preventing angiotensin II from binding to these receptors on blood vessels and other tissues. By doing so, Diovan dilates blood vessels, reducing peripheral resistance, and lowering blood pressure. The pharmacodynamic effect of Diovan is to promote vasodilation, resulting in decreased blood pressure and reduced strain on the heart, making it an effective treatment for hypertension.

Prinivil (lisinopril) 10 mg po OD:

Prinivil is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and heart failure. ACE inhibitors block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. By inhibiting this conversion, Prinivil reduces the levels of angiotensin II in the body, leading to vasodilation and decreased blood pressure. Additionally, it reduces the secretion of aldosterone, leading to a decrease in sodium and water retention. The pharmacodynamic effect of Prinivil is improved cardiac output, reduced blood pressure, and decreased workload on the heart.

Omeprazole 20 mg OD:

Omeprazole is a proton pump inhibitor (PPI) used to treat gastroesophageal reflux disease (GERD) and peptic ulcers. It inhibits the proton pump, an enzyme responsible for acid secretion in the stomach. By blocking this enzyme, omeprazole significantly reduces gastric acid production, leading to an increase in gastric pH. The pharmacodynamic effect of omeprazole is a reduction in gastric acid secretion, providing relief from acid-related symptoms and promoting healing of ulcers.

Lantus (insulin glargine) 18 units subcutaneous q AM:

Lantus is a long-acting basal insulin used to manage diabetes mellitus. It provides a steady and consistent release of insulin over an extended period, approximating the basal insulin secretion pattern of the pancreas. When injected subcutaneously, Lantus forms microprecipitates, which slow its absorption into the bloodstream. The pharmacodynamic effect of Lantus is to lower blood glucose levels by facilitating glucose uptake by cells and inhibiting the liver’s production of glucose, thus promoting glycemic control.

Humalog (insulin lispro) 19 units subcutaneous TID before meals:

Humalog is a rapid-acting insulin analog used to control postprandial blood glucose levels in patients with diabetes. It works by rapidly lowering blood glucose levels after meals. Compared to regular insulin, Humalog has a faster onset of action and a shorter duration. The pharmacodynamic effect of Humalog is to mimic the body’s natural insulin response to food intake, ensuring glucose enters the cells for energy utilization, preventing hyperglycemia, and reducing the risk of complications related to uncontrolled diabetes.

Conclusion

Understanding the pharmacodynamics of medications is essential for nurses to provide safe and effective patient care. The medications discussed above have distinct mechanisms of action, producing specific therapeutic effects to manage various medical conditions. By comprehending the pharmacodynamics of these drugs, nurses can better monitor patients, identify potential adverse effects, and optimize treatment outcomes.